SpyGlass Pharma

Public

Aliso Viejo, CaliforniaHealthcare/Wellnesshttps://spyglasspharma.com/

Last Round

IPO Announced

Feb 6, 2026

Est. Valuation

$510M

Total Funding Raised

$373.3M

Company Overview

SpyGlass Pharma is a biopharmaceutical company that develops sustained drug delivery systems for the treatment of chronic ophthalmic conditions.

Sector

Healthcare/Wellness

Verticals

HealthTech, Life Sciences

AI Layer

Non-AI

Keywords

ocular drug deliveryglaucoma implantintraocular lensdrug-eluting implantIOLsustained releaselong-acting therapycataract surgerycurrent procedural terminologyCPTmedication complianceeye drops alternativeophthalmic devicedropless glaucomabimatoprost delivery

SpyGlass Pharma Comps

Public and private peers based on sector, stage, and business model.

SpyGlass Pharma comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

SpyGlass Pharma Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
IPO Announced	Feb 6, 2026
Series D	Jun 2, 2025
Series C	Jul 10, 2023
Series B	Jan 7, 2021
Series A	May 1, 2019

View all Funding Rounds

Key People

Founding team and executive leadership

Glenn Sussman

Co-Founder And CTO

Founding Team

SpyGlass Pharma Investors

Notable investors and investment history

SpyGlass Pharma investors
Investor	Rounds
Jefferies	IPO
RA Capital Advisors	Series C, Series D
RA Capital Management	IPO, Series D, Series C
Vertex Ventures HC	IPO, Series C, Series D
New Enterprise Associates (NEA)	Series B, Series D, Series C, Series A
Gilde Healthcare	IPO, Series D
Vensana Capital	IPO, Series C, Series B, Series D

View all Investors

SpyGlass Pharma Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

SpyGlass Pharma Filings

SEC and related filings with document metadata.

Firmographic Details

HeadquartersAliso Viejo, California

Employee Range67

Year Founded2019

Last FundingFeb 6, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.